{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:02:30Z","timestamp":1771059750127,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,5]]},"DOI":"10.7759\/cureus.68737","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T19:13:38Z","timestamp":1725563618000},"source":"Crossref","is-referenced-by-count":1,"title":["Hypertensive Disorders of Pregnancy in Saudi Arabia: Evaluating Maternal and Neonatal Risks, Outcomes, and Aspirin Prophylaxis: A Review Article"],"prefix":"10.7759","author":[{"given":"Tameem M","family":"Jayousi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdeldin G","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M","family":"Jaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afrah F","family":"Aljabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaher I","family":"Banaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raha Z","family":"Ishqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/ aog.0000000000003891","article-title":"Gestational hypertension and pre-eclampsia: ACOG practice bulletin, number 222","volume":"135","author":"American College of Obstetricians and Gynecologists","year":"2020","unstructured":"American College of Obstetricians and Gynecologists. Gestational hypertension and pre-eclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020, 135:237-260. 10.1097\/ aog.0000000000003891","journal-title":"Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.36348\/sjm.2024.v09i02.003","article-title":"Prevention of pre-eclampsia in Saudi Arabia: Knowledge about risk factors and aspirin use among obstetrical care physicians - A national survey","volume":"9","author":"Alghamdi A","year":"2024","unstructured":"Alghamdi A, Alkhaledi J, Albaqawi B. Prevention of pre-eclampsia in Saudi Arabia: Knowledge about risk factors and aspirin use among obstetrical care physicians - A national survey. Saudi J Med. 2024, 9:23-32. 10.36348\/sjm.2024.v09i02.003","journal-title":"Saudi J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101625","article-title":"Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring","volume":"8","author":"Fox R","year":"2019","unstructured":"Fox R, Kitt J, Leeson P, Aye CY, Lewandowski AJ. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med. 2019, 8:4. 10.3390\/jcm8101625","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000001301","article-title":"Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses","volume":"127","author":"Ahrens KA","year":"2016","unstructured":"Ahrens KA, Silver RM, Mumford SL. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstet Gynecol. 2016, 127:689-698. 10.1097\/aog.0000000000001301","journal-title":"Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on hypertension in pnancy","volume":"122","author":"American College of Obstetricians and Gynecologists","year":"2013","unstructured":"American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on hypertension in pnancy. Obstet Gynecol. 2013, 122:1122-1131. 10.1097\/01.AOG.0000437382.03963.88","journal-title":"Obstet Gynecol"},{"key":"ref6","article-title":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","unstructured":"ACOG Committee Opinion No. 743. low-dose aspirin use during pregnancy. Obstet Gynecol. 2018, 132:44-52.","journal-title":"Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent pre-eclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement","volume":"326","author":"Davidson KW","year":"2021","unstructured":"Davidson KW, Barry MJ, Mangione CM, et al.. Aspirin use to prevent pre-eclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement. JAMA. 2021, 326:1186-1191. 10.1001\/jama.2021.14781","journal-title":"JAMA"},{"key":"ref8","unstructured":"WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. Geneva. World Health Organization. (2021). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576841\/."},{"key":"ref9","unstructured":"Hypertension in pregnancy. diagnosis and management. (2019). National Institute for Health and Care Excellence. https:\/\/www.nice.org.uk\/guidance\/qs35."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004659.pub3","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley L","year":"2019","unstructured":"Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019, 2019:10.1002\/14651858.CD004659.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. PARIS Collaborative Group","volume":"369","author":"Askie LM","year":"2007","unstructured":"Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. PARIS Collaborative Group. Lancet. 2007, 369:1791-1798. 10.1016\/S0140-6736(07)60712-0","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"160","author":"Henderson JT","year":"2014","unstructured":"Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014, 160:695-703. 10.7326\/M13-2844","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001301","article-title":"Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses","volume":"127","author":"Ahrens KA","year":"2016","unstructured":"Ahrens KA, Silver RM, Mumford SL, et al.. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstet Gynecol. 2016, 127:689-698. 10.1097\/AOG.0000000000001301","journal-title":"Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(03)00169-8","article-title":"Aspirin for prevention of pre-eclampsia in women with historical risk factors: a systematic review","volume":"101","author":"Coomarasamy A","year":"2003","unstructured":"Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of pre-eclampsia in women with historical risk factors: a systematic review. Obstet Gynecol. 2003, 101:1319-1332. 10.1016\/s0029-7844(03)00169-8","journal-title":"Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge S","year":"2017","unstructured":"Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017, 216:110.e6-120.e6. 10.1016\/j.ajog.2016.09.076","journal-title":"Am J Obstet Gynecol"},{"key":"ref16","article-title":"Hypertension in pregnancy: presentation, management and outcome - a retrospective analysis of 135 cases","volume":"9","author":"Hussein MM","year":"1998","unstructured":"Hussein MM, Mooij JM, Roujouleh H. Hypertension in pregnancy: presentation, management and outcome - a retrospective analysis of 135 cases. Saudi J Kidney Dis Transpl. 1998, 9:416-424.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.1999.557","article-title":"Hypertensive disorders of pregnancy: prevalence, classification and adverse outcomes in northwestern Saudi Arabia","volume":"19","author":"Al-Ghamdi SM","year":"1999","unstructured":"Al-Ghamdi SM, Al-Harbi AS, Khalil A, El-Yahyia AR. Hypertensive disorders of pregnancy: prevalence, classification and adverse outcomes in northwestern Saudi Arabia. Ann Saudi Med. 1999, 19:557-560. 10.5144\/0256-4947.1999.557","journal-title":"Ann Saudi Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2018.75","article-title":"Prevalence, risk factors, and fetal and maternal outcomes of hypertensive disorders of pregnancy: a retrospective study in Western Saudi Arabia","volume":"33","author":"Subki AH","year":"2018","unstructured":"Subki AH, Algethami MR, Baabdullah WM, Alnefaie MN, Alzanbagi MA, Alsolami RM, Abduljabbar HS. Prevalence, risk factors, and fetal and maternal outcomes of hypertensive disorders of pregnancy: a retrospective study in Western Saudi Arabia. Oman Med J. 2018, 33:409-415. 10.5001\/omj.2018.75","journal-title":"Oman Med J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/01443610601113961","article-title":"Severe pre-eclampsia and eclampsia in Abha, the south west region of Saudi Arabia","volume":"27","author":"Sobande AA","year":"2007","unstructured":"Sobande AA, Eskandar M, Bahar A, Abusham A. Severe pre-eclampsia and eclampsia in Abha, the south west region of Saudi Arabia. J Obstet Gynaecol. 2007, 27:150-154. 10.1080\/01443610601113961","journal-title":"J Obstet Gynaecol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310378669","article-title":"Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia","volume":"19","author":"Al Arfaj AS","year":"2010","unstructured":"Al Arfaj AS, Khalil N. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus. 2010, 19:1665-1673. 10.1177\/0961203310378669","journal-title":"Lupus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.2561390","article-title":"Aspirin as a prophylaxis in pre-eclampsia and its complications in Medina, Saudi Arabia","volume":"6","author":"Tameem J","year":"2019","unstructured":"Tameem J, Afnan EA , Shifaa Saud GA , et al.. Aspirin as a prophylaxis in pre-eclampsia and its complications in Medina, Saudi Arabia. Indo Am J Pharm Sci. 2019, 6:10.5281\/zenodo.2561390","journal-title":"Indo Am J Pharm Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31013","article-title":"Maternal and fetal outcomes of preeclampsia with and without severe features in King Abdulaziz University Hospital, Jeddah, Saudi Arabia: a retrospective study","volume":"14","author":"Mousa A","year":"2022","unstructured":"Mousa A, Mandili RL, Aljahdali M, et al.. Maternal and fetal outcomes of preeclampsia with and without severe features in King Abdulaziz University Hospital, Jeddah, Saudi Arabia: a retrospective study. Cureus. 2022, 14:e31013. 10.7759\/cureus.31013","journal-title":"Cureus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.15296\/ijwhr.2024.6002","article-title":"Awareness of pre-eclampsia and measurement of risk factors in women from the Western region of Saudi Arabia: a cross-sectional study","volume":"12","author":"Bahkali N","year":"2024","unstructured":"Bahkali N. Awareness of pre-eclampsia and measurement of risk factors in women from the Western region of Saudi Arabia: a cross-sectional study. Int J Women's Health Reprod Sci. 2024, 12:10.15296\/ijwhr.2024.6002","journal-title":"Int J Women's Health Reprod Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.54905\/disssi\/v26i128\/ms432e2512","article-title":"Level of knowledge on preeclampsia symptoms, complications, and risk factors among women in Saudi Arabia: a cross sectional study","volume":"26","author":"Gari A","year":"2022","unstructured":"Gari A, Alshanqiti W, Alshanqiti F, Alquzi R, Alsamli R, Alqahtani R. Level of knowledge on preeclampsia symptoms, complications, and risk factors among women in Saudi Arabia: a cross sectional study. Med Sci. 2022, 26:432-2512. 10.54905\/disssi\/v26i128\/ms432e2512","journal-title":"Med Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49233","article-title":"Awareness and knowledge of pre-eclampsia among Saudi women of reproductive age","volume":"15","author":"Radwan A","year":"2023","unstructured":"Radwan A, Al Naji M, Alyoubi N, et al.. Awareness and knowledge of pre-eclampsia among Saudi women of reproductive age. Cureus. 2023, 15:e49233. 10.7759\/cureus.49233","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.12890\/2022_003686","article-title":"Seronegative obstetric antiphospholipid syndrome finally treated successfully","volume":"9","author":"Alghanim KK","year":"2022","unstructured":"Alghanim KK, Alrayes HA, Aljurbua RM. Seronegative obstetric antiphospholipid syndrome finally treated successfully. Eur J Case Rep Intern Med. 2022, 9:003686. 10.12890\/2022_003686","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2022.02.003","article-title":"Aspirin use among Saudi adults: the prevalence and users' characteristics","volume":"30","author":"Alghadeer S","year":"2022","unstructured":"Alghadeer S, Alwhaibi AM, Alhossan A, et al.. Aspirin use among Saudi adults: the prevalence and users' characteristics. Saudi Pharm J. 2022, 30:340-346. 10.1016\/j.jsps.2022.02.003","journal-title":"Saudi Pharm J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/267794-hypertensive-disorders-of-pregnancy-in-saudi-arabia-evaluating-maternal-and-neonatal-risks-outcomes-and-aspirin-prophylaxis-a-review-article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T19:13:44Z","timestamp":1725563624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/267794-hypertensive-disorders-of-pregnancy-in-saudi-arabia-evaluating-maternal-and-neonatal-risks-outcomes-and-aspirin-prophylaxis-a-review-article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.68737","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}